首页> 外文期刊>Journal of Clinical Microbiology >Quantitative detection of human immunodeficiency virus (HIV) antigen by the Enzymun-Test: comparison with alternative assays and nucleic acid sequence-based amplification of HIV type 1 RNA.
【24h】

Quantitative detection of human immunodeficiency virus (HIV) antigen by the Enzymun-Test: comparison with alternative assays and nucleic acid sequence-based amplification of HIV type 1 RNA.

机译:酶联免疫吸附试验(Enzymun-Test)定量检测人类免疫缺陷病毒(HIV)抗原:与其他检测方法和基于核酸序列的HIV 1型RNA扩增进行比较。

获取原文
           

摘要

A new modular automated enzyme immunoassay (EIA) (Enzymun-Test HIV Ag: Boehringer Mannheim) for quantitative human immunodeficiency virus (HIV) antigen detection was evaluated by testing a panel of 1,506 serum samples, including seroconversions, dilution series, follow-up samples from patients under antiretroviral therapy, single serum specimens from HIV-seropositive individuals in different stages of infection, potentially cross-reactive samples, and sera from HIV-negative hospitalized patients. The Abbott HIV type 1 (HIV-1) antigen monoclonal antibody assay served as the reference assay, and nucleic acid sequence-based amplification (Organon Teknika) for quantitative amplification of HIV-1 RNA was used for follow-up of patients under antiretroviral chemotherapy. The Boehringer Mannheim and Abbott EIAs showed concordant results for the early detection of HIV antigen in all the seroconversion panels. The follow-up samples from 29 HIV-infected individuals under antiretroviral therapy gave divergent results between both antigen tests. For the detection of HIV antigen in single serum samples from HIV-infected patients in different stages of HIV infection, a higher number of positive samples was detected with the Abbott HIV-1 antigen monoclonal antibody assay in samples from patients in stages II and III of HIV infection. The Enzymun-Test detected three or more positive samples than did the Abbott assay among the samples of patients with AIDS. The concordance on a sample-to-sample basis between the Boehringer Mannheim and Abbott EIAs was 98.6%. The sensitivity of the Enzymun-Test in comparison to the reference assay was 97.2%; the specificity was 98.8%. Although no close correlation could be found between the amount of viral RNA in serum detected by nucleic acid sequence-based amplification and the concentration of HIV antigen, a high HIV-1 RNA copy number was mostly associated with high levels of HIV antigen. In conclusion, the Enzymun-Test permits accurate HIV antigen detection and offers, in contrast to previous assays, the possibility of completely automated detection.
机译:通过测试一组1,506份血清样本,包括血清转化,稀释系列和后续样本,评估了一种用于定量人类免疫缺陷病毒(HIV)抗原检测的新型模块化自动酶免疫测定(EIA)(Enzymun-Test HIV Ag:Boehringer Mannheim)接受抗逆转录病毒治疗的患者的样本,来自处于感染不同阶段的HIV血清阳性个体的单个血清标本,可能具有交叉反应的样本以及来自HIV阴性住院患者的血清。雅培HIV 1型(HIV-1)抗原单克隆抗体测定用作参考测定,并使用用于定量扩增HIV-1 RNA的基于核酸序列的扩增(Organon Teknika)进行抗逆转录病毒化学疗法的患者随访。勃林格·曼海姆(Boehringer Mannheim)和雅培(Abbott)EIA显示出在所有血清转化面板中早期检测HIV抗原的一致结果。在接受抗逆转录病毒治疗的29名HIV感染者的后续样本中,两种抗原测试的结果不一致。为了检测来自处于不同阶段HIV感染的HIV感染患者的单一血清样品中的HIV抗原,使用雅培HIV-1抗原单克隆抗体测定法可检测出来自II期和III期患者的样品中检测到更多阳性样品。 HIV感染。在艾滋病患者的样本中,酶测法比雅培测定法检测到三个或更多阳性样本。勃林格殷格翰公司与雅培EIA之间的抽样一致性为98.6%。与参考测定相比,酶测的灵敏度为97.2%;特异性为98.8%。尽管在通过基于核酸序列的扩增检测到的血清中病毒RNA的量与HIV抗原的浓度之间没有发现密切的相关性,但高HIV-1 RNA拷贝数主要与高水平的HIV抗原有关。总之,酶检测可以准确检测HIV抗原,并且与以前的检测方法相比,可以提供全自动检测的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号